Fibrodysplasia Ossificans Progressiva
📧 Sign up to get email alerts when something new happens for Fibrodysplasia Ossificans Progressiva.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). [Phase 2]
Phase 2 trial evaluating two oral dosing regimens of fidrisertib (IPN60130) for fibrodysplasia ossificans progressiva has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) [Phase 3]
A Phase 3 trial evaluating garetosmab versus placebo in adults with Fibrodysplasia Ossificans Progressiva; the study is active but not recru…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
This update reports on a completed non-interventional study collecting clinical characteristics and mortality data of US patients with fibro…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. [Phase 3]
A completed Phase 3 rollover study evaluating the safety and efficacy of palovarotene capsules in participants with fibrodysplasia ossifican…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP) [Phase 2]
Open-label extension study of palovarotene for Fibrodysplasia Ossificans Progressiva (Phase 2) with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Saracatinib Trial TO Prevent FOP [Phase 2]
A Phase 2 clinical trial evaluating saracatinib to prevent Fibrodysplasia Ossificans Progressiva is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. [Phase 3]
Phase 3 trial of palovarotene for fibrodysplasia ossificans progressiva has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva [Phase 2]
Phase 2 trial update for REGN2477 in fibrodysplasia ossificans progressiva (FOP) evaluating safety, tolerability, and effects on abnormal bo…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects [Phase 2]
Phase 2 clinical trial evaluating episodic in-home administration of palovarotene in Fibrodysplasia Ossificans Progressiva has been terminat…
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects [Phase 2]
Phase 2 trial evaluating palovarotene for preosseous flare-ups in Fibrodysplasia Ossificans Progressiva has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Urine Sample Collection From FOP Patients
A completed clinical trial update noting urine sample collection from Fibrodysplasia Ossificans Progressiva patients (NCT02066324).